Skip Navigation
 

Funding


RCDC

Project Listing by Category


Back to Estimates of Funding for Various Research, Condition, and Disease Categories (RCDC) Click the column headings to sort project listings.
  Help
12
CategoryFYFunding ICProject NumberSub Project #Project TitlePI NameOrg NameState / CountryAmount
Lymphoma 2017 NCI 5R01CA179062-03 Role of Specific Histone Deacetylases in Lymphoma Immunobiology and Therapy SOTOMAYOR, EDUARDO GEORGE WASHINGTON UNIVERSITY DC $362,569
Lymphoma 2017 NIEHS 5U13ES026496-02 Childhood Leukemia International Consortium Scientific Annual Meetings METAYER, CATHERINE UNIVERSITY OF CALIFORNIA BERKELEY CA $15,000
Lymphoma 2017 NCI 1K22CA207598-01 The Role of Suv420h1 Histone Methyltransferase in MYC-Driven Tumorigenesis LI, YULIN METHODIST HOSPITAL RESEARCH INSTITUTE TX $188,379
Lymphoma 2017 NIAID 5R01AI105114-04 Viral Interface with an Interferon-Induced Gene REICH, NANCY STATE UNIVERSITY NEW YORK STONY BROOK NY $463,541
Lymphoma 2017 NIAID 5R01AI072194-08 Elucidation of Immunoglobulin Class Switch Recombination CHAUDHURI, JAYANTA SLOAN-KETTERING INST CAN RESEARCH NY $439,750
Lymphoma 2017 NIAID 5R01AI114556-03 Targeting Fnip1 to disrupt B cell development, metabolism, and transformation IRITANI, BRIAN UNIVERSITY OF WASHINGTON WA $386,250
Lymphoma 2017 NCI 5R01CA184187-03 DNA-PKCS Phosphorylation in DNA Repair and Chromosomal Translocations ZHA, SHAN COLUMBIA UNIVERSITY HEALTH SCIENCES NY $366,000
Lymphoma 2017 NIAID 5R01AI114557-03 Neutralizing Antibodies in Acute and Persistent Epstein-Barr Virus Infection WANG, FREDERICK BRIGHAM AND WOMEN'S HOSPITAL MA $593,287
Lymphoma 2017 NIGMS 5R01GM111741-03 High-throughput informatics for antibodies MACCARTHY, THOMAS STATE UNIVERSITY NEW YORK STONY BROOK NY $266,488
Lymphoma 2017 NIDCR 5R01DE025567-02 Atomic structure of Kaposi's sarcoma-associated herpesvirus capsid ZHOU, Z UNIVERSITY OF CALIFORNIA LOS ANGELES CA $385,000
Lymphoma 2017 NCI 5F31CA183569-04 The Role of ATF4 in Promoting c-Myc Induced Lymphomagenesis TAMEIRE, FEVEN UNIVERSITY OF PENNSYLVANIA PA $30,934
Lymphoma 2017 NCI 5R01CA182461-04 Defining the impact of clonal evolution on chronic lymphocytic leukemia WU, CATHERINE DANA-FARBER CANCER INST MA $362,378
Lymphoma 2017 NCI 5R01CA164178-05 A novel NKG2D-specific BiTE cancer immunotherapy SENTMAN, CHARLES DARTMOUTH COLLEGE NH $336,150
Lymphoma 2017 NIAID 5R01AI106393-05 BH3-only protein targeting by HHV-8 NICHOLAS, JOHN JOHNS HOPKINS UNIVERSITY MD $405,000
Lymphoma 2017 NCI 5F31CA192835-03 Intratumoral Heterogeneity and Tumor Evolution in Lymphoma KASTENHUBER, EDWARD SLOAN-KETTERING INST CAN RESEARCH NY $44,044
Lymphoma 2017 NIGMS 5R01GM073857-10 Mechanism and Uses of Transmembrane Helix Insertion by Soluble Peptides ENGELMAN, DONALD YALE UNIVERSITY CT $569,403
Lymphoma 2017 NIAID 5R01AI108407-03 Role of MHV68 miRNAs in latencyand pathogenesis TIBBETTS, SCOTT UNIVERSITY OF FLORIDA FL $396,236
Lymphoma 2017 NCI 5R01CA183444-04 Molecular Evaluation of Targeted Therapies in Lymphoid Malignancies BYRD, JOHN OHIO STATE UNIVERSITY OH $523,187
Lymphoma 2017 NCI 5R21CA200420-02 The effect of statins on B cell dysfunction in HIV infection MARTINEZ-MAZA, OTONIEL UNIVERSITY OF CALIFORNIA LOS ANGELES CA $215,985
Lymphoma 2017 NIAID 5R21AI122670-02 Developing a new model for EBV-mediated T cell diseases PELANDA, ROBERTA UNIVERSITY OF COLORADO DENVER CO $233,250
Lymphoma 2017 NCI 5R01CA172492-05 Role of MLL2 Gene Inactivation in B cell Non Hodgkin Lymphoma PASQUALUCCI, LAURA COLUMBIA UNIVERSITY HEALTH SCIENCES NY $332,000
Lymphoma 2017 NIAID 5R37AI037526-23 Class Switch Recombination in B Lymphocytes NUSSENZWEIG, MICHEL ROCKEFELLER UNIVERSITY NY $423,750
Lymphoma 2017 NCI 5R00CA183914-04 A Novel Oncogenic Role for Cdc20 Implications in Adult T Cell Leukemia Treatment WAN, LIXIN H. LEE MOFFITT CANCER CTR & RES INST FL $254,171
Lymphoma 2017 NCI 5R01CA196266-02 A Novel Strategy Targeting TfR1 for the Prevention/Treatment of AIDS-related NHL PENICHET, MANUEL UNIVERSITY OF CALIFORNIA LOS ANGELES CA $502,591
Lymphoma 2017 NCI 5R01CA190384-03 The genomic pathogenesis of Follicular Lymphoma MALEK, SAMI UNIVERSITY OF MICHIGAN MI $541,994
Lymphoma 2017 NCI 5R01CA194263-02 Understanding Psychosocial and Immunologic Responses in Indolent Lymphoproliferative Disorders FANG, CAROLYN RESEARCH INST OF FOX CHASE CAN CTR PA $632,188
Lymphoma 2017 NCI 5R01CA180758-04 KSHV interactions with host inflammasome components CHANDRAN, BALA ROSALIND FRANKLIN UNIV OF MEDICINE & SCI IL $63,355
Lymphoma 2017 NCI 5P01CA094237-15 7520 VACCINATION TO ENHANCE T CELL IMMUNOTHERAPY HESLOP, HELEN BAYLOR COLLEGE OF MEDICINE TX $295,519
Lymphoma 2017 NCI 5K22CA184308-03 Dissecting Genetic and Epigenetic variation in the Cancer Regulome HODGES, EMILY VANDERBILT UNIVERSITY TN $157,854
Lymphoma 2017 NIAID 5R21AI124172-02 Rab7 and NF-kappaB in B cell activation and dysregulation XU, ZHENMING UNIVERSITY OF TEXAS HLTH SCIENCE CENTER TX $187,213
Lymphoma 2017 NCI 5P30CA008748-51 7551 Monoclonal Antibody WEIS-GARCIA, FRANCES SLOAN-KETTERING INST CAN RESEARCH NY $308,192
Lymphoma 2017 NCI 5R01CA165469-05 Role of Tcl1 and Par-4 in regulation of chronic lymphocytic leukemia BONDADA, SUBBARAO UNIVERSITY OF KENTUCKY KY $381,420
Lymphoma 2017 NCI 5R01CA075922-21 Rhesus HHV-8 homologue in AIDS-related malignancies WONG, SCOTT OREGON HEALTH & SCIENCE UNIVERSITY OR $794,238
Lymphoma 2017 NCI 5R01CA180813-04 Kaposi's Sarcoma-associated Herpesvirus Mimics of Cellular microRNAs GOTTWEIN, EVA NORTHWESTERN UNIVERSITY AT CHICAGO IL $320,588
Lymphoma 2017 NCI 5R01CA166144-06 Development of Therapeutic CD59 inhibitor for treating B-cell malignancies QIN, XUEBIN TEMPLE UNIV OF THE COMMONWEALTH PA $327,938
Lymphoma 2017 NIAID 5R01AI106676-04 Epstein Barr virus antisense transcription FLEMINGTON, ERIK TULANE UNIVERSITY OF LOUISIANA LA $376,250
Lymphoma 2017 NCI 5R01CA168482-05 HIV-driven B cell activation: role in the genesis of AIDS-related lymphoma MARTINEZ-MAZA, OTONIEL UNIVERSITY OF CALIFORNIA LOS ANGELES CA $319,550
Lymphoma 2017 NCI 5UM1CA173642-05 Women's Health Initiative Cancer Survivor Cohort ANDERSON, GARNET FRED HUTCHINSON CANCER RESEARCH CENTER WA $2,260,718
Lymphoma 2017 NCI 5R01CA091791-15 Reactivation of Kaposi's Sarcoma-Associated Herpesvirus SUN, REN UNIVERSITY OF CALIFORNIA LOS ANGELES CA $284,547
Lymphoma 2017 NCI 2P30CA006516-52 5400 Program 6: Lymphoma and Myeloma SHIPP, MARGARET DANA-FARBER CANCER INST MA $43,077
Lymphoma 2017 NCI 5R01CA166450-05 Characterizing tumor suppressive functions of microRNAs in B-cell neoplasia RAO, DINESH UNIVERSITY OF CALIFORNIA LOS ANGELES CA $319,550
Lymphoma 2017 NIGMS 1P20GM121288-01 6063 Project 1-Role of HERV-K Reactivation in AIDS-related Kaposi's Sarcoma QIN, ZHIQIANG LSU HEALTH SCIENCES CENTER LA $241,864
Lymphoma 2017 NCI 5F30CA189433-03 Investigating the function of MTBP in lymphoma PUCCETTI, MATTHEW VANDERBILT UNIVERSITY TN $6,135
Lymphoma 2017 NIAID 5R21AI115313-02 Targeting B Cell MicroRNA in Post-Transplant EBV-Associated B Cell Lymphoma MARTINEZ, OLIVIA STANFORD UNIVERSITY CA $197,731
Lymphoma 2017 NIAID 5R01AI124186-02 RNA-directed targeting of AID in immunity and genomic integrity CHAUDHURI, JAYANTA SLOAN-KETTERING INST CAN RESEARCH NY $428,500
Lymphoma 2017 NCI 5R01CA193140-02 Targeting the Ig-light chains with CAR-T cells in lymphoid tumors DOTTI, GIANPIETRO UNIV OF NORTH CAROLINA CHAPEL HILL NC $569,255
Lymphoma 2017 NIEHS 5R01ES021832-05 Endocrine disrupter modulation of SXR in development and lymphomagenesis BLUMBERG, BRUCE UNIVERSITY OF CALIFORNIA-IRVINE CA $364,901
Lymphoma 2017 NIAID 5R01AI018757-35 Host Immunity to EBV Infection in Vitro and in Vivo THORLEY-LAWSON, DAVID TUFTS UNIVERSITY BOSTON MA $412,500
Lymphoma 2017 NCI 5R01CA170023-05 Roles of Epstein-Barr virus nuclear antigens 2 and LP in B cell proliferation ZHAO, BO BRIGHAM AND WOMEN'S HOSPITAL MA $393,163
Lymphoma 2017 NCI 5K22CA188106-03 Characterization of replication-mediated DNA damage in B lymphocytes BARLOW, JACQUELINE UNIVERSITY OF CALIFORNIA AT DAVIS CA $162,000
Lymphoma 2017 NCI 5R01CA119917-10 Studying the role of KSHV-encoded miRNAs RENNE, ROLF UNIVERSITY OF FLORIDA FL $301,913
Lymphoma 2017 NCI 5R01CA186935-03 Regulation of gamma delta T cell immunoediting by novel phosphoantigens WIEMER, ANDREW UNIVERSITY OF CONNECTICUT STORRS CT $377,822
Lymphoma 2017 NIDCR 5R01DE025208-03 KSHV latent infection replication KAYE, KENNETH BRIGHAM AND WOMEN'S HOSPITAL MA $443,750
Lymphoma 2017 NCI 1R01CA211963-01 Ionizing radiation induced hematological malignancies ZHOU, DAOHONG UNIV OF ARKANSAS FOR MED SCIS AR $355,340
Lymphoma 2017 NCI 5R01CA179363-04 Molecular signature of inflammation MALARKANNAN, SUBRAMANIAM MEDICAL COLLEGE OF WISCONSIN WI $321,921
Lymphoma 2017 NCI 5R21CA202525-02 Targeting CXCR5 for angioimmunoblastic T-cell lymphoma LOLIS, ELIAS YALE UNIVERSITY CT $175,881
Lymphoma 2017 NCI 1R01CA213138-01 CD25-mediated feedback control of BCR-signaling and its oncogenic mimics MÜSCHEN, MARKUS BECKMAN RESEARCH INSTITUTE/CITY OF HOPE CA $395,738
Lymphoma 2017 NCI 1UH2CA206127-01A1 Molecular diagnostic and prognostic signatures for PTCL IQBAL, JAVEED UNIVERSITY OF NEBRASKA MEDICAL CENTER NE $205,470
Lymphoma 2017 NIBIB 5R21EB020237-02 Switchable Molecular Nanoprobes for Fast and Specific Intraoperative Diagnosis of Brain Tumors YAN, HAO ARIZONA STATE UNIVERSITY-TEMPE CAMPUS AZ $177,526
Lymphoma 2017 NHLBI 5R01HL116452-05 The role of the SF3B1 splicing factor in chronic lymphocytic leukemia WU, CATHERINE DANA-FARBER CANCER INST MA $434,621
Lymphoma 2017 NCI 5R01CA174462-05 New Models and Treatments for AIDS-related Lymphoma KENNEY, SHANNON UNIVERSITY OF WISCONSIN-MADISON WI $416,873
Lymphoma 2017 NCI 5F31CA196209-03 Examining the Role of Rho Kinase in the Pathogenesis of ABC-DLBCL RICKER, EDD WEILL MEDICAL COLL OF CORNELL UNIV NY $44,044
Lymphoma 2017 NIAID 1R21AI128598-01 Role of Siglec-10/G as a tumor suppressor in B-cells MACAULEY, MATTHEW SCRIPPS RESEARCH INSTITUTE CA $336,875
Lymphoma 2017 NCI 5R01CA070723-20 Genetic Analysis of EBV's Immortalizing Genes SUGDEN, WILLIAM UNIVERSITY OF WISCONSIN-MADISON WI $291,588
Lymphoma 2017 NCI 5R01CA174794-05 Brain Integrity in Survivors of Childhood Cancer Treated with Thoracic Radiation KRULL, KEVIN ST. JUDE CHILDREN'S RESEARCH HOSPITAL TN $605,760
Lymphoma 2017 NIAID 5R01AI110328-04 Viral Long Noncoding RNA Functions in Epstein-Barr Virus Infection SAMPLE, JEFFERY PENNSYLVANIA STATE UNIV HERSHEY MED CTR PA $378,130
Lymphoma 2017 NCI 5R01CA184384-04 Prognostic Metabolic Signatures of Cancers Through Mass Spectrometry Imaging FELSHER, DEAN STANFORD UNIVERSITY CA $528,101
Lymphoma 2017 NCI 5R01CA076167-14 Genetic Analysis of Myeloproliferative Disease COWELL, JOHN AUGUSTA UNIVERSITY GA $307,800
Lymphoma 2017 NIAID 5R21AI124129-02 Generation of a mouse expressing a photoactivatable Cre recombinase SCHWAB, SUSAN NEW YORK UNIVERSITY SCHOOL OF MEDICINE NY $211,875
Lymphoma 2017 NIAID 5R01AI123420-02 Targeting Epstein-Barr Virus super-enhancers ZHAO, BO BRIGHAM AND WOMEN'S HOSPITAL MA $443,750
Lymphoma 2017 NIAID 5U01AI104342-05 Biomarkers for Post-Transplant Lymphoproliferative Disorders in Children ESQUIVEL, CARLOS STANFORD UNIVERSITY CA $1,363,549
Lymphoma 2017 NCI 5R35CA200422-02 Molecular Basis of KSHV oncogenesis JUNG, JAE UNIVERSITY OF SOUTHERN CALIFORNIA CA $958,770
Lymphoma 2017 NCI 5R01CA124332-11 Regulation of KSHV infection and replication by MAPK pathways GAO, SHOU-JIANG UNIVERSITY OF SOUTHERN CALIFORNIA CA $304,095
Lymphoma 2017 NCI 5R01CA137488-22 Two Compartment Models to Improve Brain Tumor Therapy NEUWELT, EDWARD OREGON HEALTH & SCIENCE UNIVERSITY OR $447,921
Lymphoma 2017 NCI 5R01CA188561-04 The Tumor Suppressor Function of Dnmt3a in Chronic Lymphocytic Leukemia OPAVSKY, RENE UNIVERSITY OF FLORIDA FL $348,844
Lymphoma 2017 NIGMS 5K99GM117302-02 A novel role for 53BP1 independent of damage that controls chromatin structure PEREIRA DA ROCHA, PEDRO NEW YORK UNIVERSITY SCHOOL OF MEDICINE NY $90,000
Lymphoma 2017 NCI 1R33CA212968-01 LETSSGo: Lymphoma-on-chip Engineered Technology for Single-Organoid Sequencing and Genomics SINGH, ANKUR CORNELL UNIVERSITY NY $371,216
Lymphoma 2017 NIAID 5U19AI109965-04 5822 Innate Recognition of Human Herpesviruses DAMANIA, BLOSSOM UNIV OF NORTH CAROLINA CHAPEL HILL NC $415,379
Lymphoma 2017 NCI 5R01CA177319-05 The Role of NOTCH1 in the Pathogenesis of CLL. DALLA-FAVERA, RICCARDO COLUMBIA UNIVERSITY HEALTH SCIENCES NY $358,315
Lymphoma 2017 NCI 5R01CA172724-03 Novel Strategies to Target Leukemia-Stromal Interactions HUANG, PENG UNIVERSITY OF TX MD ANDERSON CAN CTR TX $366,000
Lymphoma 2017 NIDCR 5R01DE025804-02 Role of IKK epsilon in KSHV/HHV8 associated malignancies CHAUDHARY, PREET UNIVERSITY OF SOUTHERN CALIFORNIA CA $412,500
Lymphoma 2017 NCI 5R01CA142698-08 Molecular mechanism and relevance of microRNAs in DSB repair pathway choice CHOWDHURY, DIPANJAN DANA-FARBER CANCER INST MA $409,002
Lymphoma 2017 NCI 5F30CA183263-03 Multifunctional polymeric carriers for the intracellular delivery of protein cancer therapeutics KERN, HANNA UNIVERSITY OF WASHINGTON WA $38,095
Lymphoma 2017 NCI 5R01CA184728-03 Targeting Granzyme B to Separate GVH from GVL Responses CAO, XUEFANG ROSWELL PARK CANCER INSTITUTE CORP NY $401,456
Lymphoma 2017 NIDCR 5R01DE025994-02 Targeting Apoptosis and Immune Control of Epstein-Barr Virus Infected Tonsillar B Cells LUFTIG, MICAH DUKE UNIVERSITY NC $437,944
Lymphoma 2017 NIDCR 5R01DE025985-02 KSHV Replication in Oral Epithelial Cells IZUMIYA, YOSHIHIRO UNIVERSITY OF CALIFORNIA AT DAVIS CA $392,500
Lymphoma 2017 NCI 1R01CA204258-01A1 Clinical Pregnancy Outcomes in Adolescent and Young Adult Female Cancer Survivors NICHOLS, HAZEL UNIV OF NORTH CAROLINA CHAPEL HILL NC $675,579
Lymphoma 2017 NCI 1R01CA201135-01A1 Mechanisms mediating resistance to ibrutinib in Non-Hodgkin's lymphoma JAMES, RICHARD SEATTLE CHILDREN'S HOSPITAL WA $447,954
Lymphoma 2017 NCI 5R01CA162411-05 Novel monocyte effector function in CLL immune therapy TRIDANDAPANI, SUSHEELA OHIO STATE UNIVERSITY OH $319,550
Lymphoma 2017 NCI 5R01CA204621-02 Modulation of Host Cell Exosome Content and Function by EBV LMP1 MECKES, DAVID FLORIDA STATE UNIVERSITY FL $341,410
Lymphoma 2017 NCI 1R01CA203923-01A1 IRF-1: a brake to limit gammaherpesvirus infection and pathogenesis TARAKANOVA, VERA MEDICAL COLLEGE OF WISCONSIN WI $352,275
Lymphoma 2017 NCI 2R01CA158073-06A1 The Role of ATM in Suppression of Lymphomas ZHA, SHAN COLUMBIA UNIVERSITY HEALTH SCIENCES NY $380,000
Lymphoma 2017 NCI 5R01CA176647-05 Targeting stabilized mutant p53 protein MOLL, UTE STATE UNIVERSITY NEW YORK STONY BROOK NY $356,514
Lymphoma 2017 NCI 5R01CA193655-03 Defining the Functional Role of Mutations in Diffuse Large B cell Lymphoma DAVE, SANDEEP DUKE UNIVERSITY NC $510,478
Lymphoma 2017 NCI 5R01CA076445-16 Studies of HHV-8 vIL-6 Function NICHOLAS, JOHN JOHNS HOPKINS UNIVERSITY MD $384,750
Lymphoma 2017 NCI 5P01CA174653-04 6845 Pathology BHAGAT, GOVIND COLUMBIA UNIVERSITY NY $188,903
Lymphoma 2017 NCI 5P01CA174653-04 6841 The Role of CTIP in Lymphocyte Development and Lymphomagenesis ZHA, SHAN COLUMBIA UNIVERSITY NY $364,327
Lymphoma 2017 NCI 5R21CA206104-02 Mechanisms of c-CBL Regulation in Cutaneous T-Cell Lymphoma (CTCL) WOOD, GARY UNIVERSITY OF WISCONSIN-MADISON WI $166,388
Lymphoma 2017 NIDCR 5R01DE026003-02 Targeting an immune kinase to purge KSHV latent infection FENG, PINGHUI UNIVERSITY OF SOUTHERN CALIFORNIA CA $676,564
Lymphoma 2017 NCI 5R01CA151898-07 CRLF2 signaling in B-cell acute lymphoblastic leukemia WEINSTOCK, DAVID DANA-FARBER CANCER INST MA $392,969
Lymphoma 2017 NIAID 5R01AI076183-15 Structural and Functional Studies of gp42 and HLA Class 2 in EBV Entry LONGNECKER, RICHARD NORTHWESTERN UNIVERSITY AT CHICAGO IL $507,585
Lymphoma 2017 NCI 5R01CA063417-17 PROLIFERATIVE EFFECTS OF HTLV-1 RATNER, LEE WASHINGTON UNIVERSITY MO $158,641
Lymphoma 2017 NCI 2R01CA149707-06A1 Investigating the functions of the miR-17~92 family of oncogenic microRNA clusters VENTURA, ANDREA SLOAN-KETTERING INST CAN RESEARCH NY $385,650
Lymphoma 2017 NCI 5R01CA164641-05 Natural Killer Cell Regulation by PRDM1 and IRF4/8 WRIGHT, KENNETH H. LEE MOFFITT CANCER CTR & RES INST FL $321,210
Lymphoma 2017 NCI 5R01CA177600-05 Regulation of CARD11 signaling in normal and dysregulated lymphocyte development POMERANTZ, JOEL JOHNS HOPKINS UNIVERSITY MD $336,150
Lymphoma 2017 NCI 5F30CA183520-03 Targeting CD37 and elucidating its role in B-cell malignancy BECKWITH, KYLE OHIO STATE UNIVERSITY OH $49,044
Lymphoma 2017 NCI 5R01CA177292-05 Targeted Therapy for Lymphoid Malignancies BYRD, JOHN OHIO STATE UNIVERSITY OH $536,708
Lymphoma 2017 NCI 5R01CA187415-03 MYC as a Biomarker in Aggressive Non-Hodgkin Lymphoma LI, YONG CLEVELAND CLINIC LERNER COM-CWRU OH $448,485
Lymphoma 2017 NCI 5R01CA155010-07 Personal tumor neoantigens for immunity against chronic lymphocytic leukemia WU, CATHERINE DANA-FARBER CANCER INST MA $675,300
Lymphoma 2017 NCI 5P30CA086862-17 7673 Program 4: Cancer Epidemiology and Population Science LYNCH, CHARLES UNIVERSITY OF IOWA IA $25,763
Lymphoma 2017 NCI 5P01CA049605-28 5891 Immune Regulation in HCT NEGRIN, ROBERT STANFORD UNIVERSITY CA $1,151,709
Lymphoma 2017 NCI 5P01CA049605-28 5892 Auto-lmmunotransplantation for Lymphoma LEVY, RONALD STANFORD UNIVERSITY CA $199,532
Lymphoma 2017 NCI 5P01CA049605-28 5893 Memory CDS T Cells for GVL STROBER, SAMUEL STANFORD UNIVERSITY CA $150,530
Lymphoma 2017 NCI 5P01CA049605-28 5894 Improving Graft-versus-Leukemia Alloimmunity against CLL MIKLOS, DAVID STANFORD UNIVERSITY CA $135,777
Lymphoma 2017 NCI 5P01CA049605-28 5897 Administration and Clinical Trial Coordination NEGRIN, ROBERT STANFORD UNIVERSITY CA $258,741
Lymphoma 2017 NCI 5P01CA049605-28 5898 Biostatistics and Data Management LAVORI, PHILIP STANFORD UNIVERSITY CA $186,993
Lymphoma 2017 NCI 5P01CA049605-28 5899 Molecular Diagnostics ZEHNDER, JAMES STANFORD UNIVERSITY CA $239,455
Lymphoma 2017 NCI 5P01CA049605-28 5900 Cell Processing and Sample Distribution Laboratory LOWSKY, ROBERT STANFORD UNIVERSITY CA $377,263
Lymphoma 2017 NCI 5F30CA206343-02 The cyclic AMP/phosphodiesterase4 axis regulates proximal B cell receptor signaling and offers a new therapeutic strategy for B cell lymphomas COONEY, JEFFREY UNIVERSITY OF TEXAS HLTH SCIENCE CENTER TX $32,244
Lymphoma 2017 NCI 5P01CA174439-05 8216 Role of LANA-RBP-jk During Early KSHV Infection ROBERTSON, ERLE UNIVERSITY OF PENNSYLVANIA PA $341,337
Lymphoma 2017 NCI 5P01CA174439-05 8218 Chromatin Regulation of KSHV Primary Infection LIEBERMAN, PAUL WISTAR INSTITUTE PA $359,680
Lymphoma 2017 NCI 5R01CA188286-03 SEQUENCE-SPECIFIC CHROMATIN MODIFIERS; NOVEL PROTEIN THERAPEUTICS FOR B CELL LYMPHOMA PAYTON, JACQUELINE WASHINGTON UNIVERSITY MO $348,844
Lymphoma 2017 NCI 5R21CA195431-02 Role of Follicular Dendritic Cells in B lymphoma APGAR, JOHN SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE CA $212,063
Lymphoma 2017 NIAMS 1F31AR070094-01A1 Uncovering Antigenic and Microbial Contributors to the Pathogenesis of Cutaneous T Cell Lymphoma FANOK, MELANIA NEW YORK UNIVERSITY SCHOOL OF MEDICINE NY $43,576
Lymphoma 2017 NCI 5R01CA193541-03 Predicting Clinical Outcome After Traditional and Ibrutinib-based Therapy In Chronic Lymphocytic Leukemia KAY, NEIL MAYO CLINIC ROCHESTER MN $510,400
Lymphoma 2017 NCI 1F31CA213668-01 CD40L-Modified Chimeric Antigen Receptor (CAR) T Cells KUHN, NICHOLAS SLOAN-KETTERING INST CAN RESEARCH NY $44,044
Lymphoma 2017 NCI 5F31CA206236-02 Computational Analysis of Subclonal Evolution in Chronic Lymphocytic Leukemia FAN, JEAN HARVARD MEDICAL SCHOOL MA $12,568
Lymphoma 2017 NCI 5R01CA192928-03 Dual targeting of XPO1 and BTK in B cell malignancies LAPALOMBELLA, ROSA OHIO STATE UNIVERSITY OH $512,016
Lymphoma 2017 NCI 2R13CA124293-10 Annual International Primary CNS Lymphoma Collaborative Group Meeting BATCHELOR, TRACY MASSACHUSETTS GENERAL HOSPITAL MA $5,000
Lymphoma 2017 NCI 5R01CA182947-04 Inhibition of PGE2 for mobilization of autologous peripheral blood stem cells FARAG, SHERIF INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS IN $321,933
Lymphoma 2017 NCI 5R01CA093606-15 Regulation of EBV Latency by EBNA1 LIEBERMAN, PAUL WISTAR INSTITUTE PA $329,956
Lymphoma 2017 NCI 1R01CA214046-01 Targeted Therapies for Richters Transformation LAPALOMBELLA, ROSA OHIO STATE UNIVERSITY OH $452,551
Lymphoma 2017 NCI 5R01CA129037-10 Replicative Senescence as a Tumor Suppressive Mechanism CHANG, SANDY YALE UNIVERSITY CT $306,860
Lymphoma 2017 NCI 5R01CA181319-04 Targeting Stem-Cell Dependent Drug Resistance in Human MCL MCCARTY, NAMI UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON TX $313,723
Lymphoma 2017 NIAID 5R01AI121300-02 Non-coding RNAs in Gammaherpesvirus Infection and Disease VAN DYK, LINDA UNIVERSITY OF COLORADO DENVER CO $385,420
Lymphoma 2017 NCI 5R01CA184922-04 (PQD1) lmpact of cytotoxic and targeted therapy on clonal evolution of CLL WU, CATHERINE DANA-FARBER CANCER INST MA $553,684
Lymphoma 2017 NIAID 5R01AI105000-05 KSHV Lytic DNA Replication and its Control Mechanism VERMA, SUBHASH UNIVERSITY OF NEVADA RENO NV $356,575
Lymphoma 2017 NCI 5R01CA187299-03 Epigenetic Gene Regulation by JAK1 Kinase in Diffuse Large B-Cell Lymphoma RUI, LIXIN UNIVERSITY OF WISCONSIN-MADISON WI $349,988
Lymphoma 2017 NCI 5P01CA022443-40 6859 Controlling the Latent-to-Lytic Switch in Epstein-Barr Virus MERTZ, JANET UNIVERSITY OF WISCONSIN-MADISON WI $345,176
Lymphoma 2017 NCI 5P01CA022443-40 6863 miRNA and v-Cdks: Independent Drivers OF EBV and HCMV Replication and Oncogenesi KENNEY, SHANNON UNIVERSITY OF WISCONSIN-MADISON WI $392,337
Lymphoma 2017 NCI 5R01CA185372-04 (PQD5) A novel genetic strategy to predict efficacy of anti-CD20 antibodies RICHARDS, KRISTY CORNELL UNIVERSITY NY $321,625
Lymphoma 2017 NIAID 5R01AI109644-04 Differential mechanisms for RORgammat-regulated thymocyte development and Th17 di SUN, ZUOMING BECKMAN RESEARCH INSTITUTE/CITY OF HOPE CA $420,000
Lymphoma 2017 NCI 5R01CA203721-02 Transforming the diagnosis and care of patients with CTCL using TCR sequencing CLARK, RACHAEL BRIGHAM AND WOMEN'S HOSPITAL MA $680,545
Lymphoma 2017 NCI 5R01CA181699-04 Investigating the roles of lncRNAs in cancer and development VENTURA, ANDREA SLOAN-KETTERING INST CAN RESEARCH NY $419,643
Lymphoma 2017 NIAID 5R21AI122068-02 Antibody-based prophylactic EBV vaccine SNAPPER, CLIFFORD HENRY M. JACKSON FDN FOR THE ADV MIL/MED MD $192,510
Lymphoma 2017 NCI 1P01CA214091-01 6349 "Project 1" KSHV-encoded Inc RNAs and alteration of host IncRNA expression RENNE, ROLF UNIVERSITY OF FLORIDA FL $241,215
Lymphoma 2017 NCI 1P01CA214091-01 6350 "Project 2" Epstein-Barr virus LMP2 IncRNAs FLEMINGTON, ERIK TULANE UNIVERSITY OF LOUISIANA LA $330,828
Lymphoma 2017 NCI 1P01CA214091-01 6351 "Project 3" MHV68 IncRNA/miRNA interaction in latency and lympomagenesis TIBBETTS, SCOTT UNIVERSITY OF FLORIDA FL $255,393
Lymphoma 2017 NCI 1P01CA214091-01 6353 "Core B" Virus RNA-seq and Bioinformatics Core FLEMINGTON, ERIK TULANE UNIVERSITY OF LOUISIANA LA $277,492
Lymphoma 2017 NCI 5R01CA186775-04 Development of a Small Molecule Inhibitor for KSHV LANA LIEBERMAN, PAUL WISTAR INSTITUTE PA $394,250
Lymphoma 2017 NCI 5P01CA125066-09 7158 Isolation Chemistry of Tropical Plants and Biological Evaluation KINGHORN, ALAN OHIO STATE UNIVERSITY OH $252,341
Lymphoma 2017 NCI 5R01CA193624-03 Development of a Novel Inducer for EBV Lytic Therapy LIEBERMAN, PAUL WISTAR INSTITUTE PA $546,954
Lymphoma 2017 NCI 5R01CA073507-19 In Vivo Model of Epstein-Barr Virus Latency LONGNECKER, RICHARD NORTHWESTERN UNIVERSITY AT CHICAGO IL $372,677
Lymphoma 2017 NCI 5F32CA203217-02 Role of branched-chain amino catabolism in lymphopoiesis and lymphomagenesis FERNANDEZ, MARIO H. LEE MOFFITT CANCER CTR & RES INST FL $60,990
Lymphoma 2017 NCI 5R01CA183876-04 Towards The Chemotherapy-Free Treatment of Follicular Lymphoma WENDEL, HANS-GUIDO SLOAN-KETTERING INST CAN RESEARCH NY $475,801
Lymphoma 2017 NCI 5F30CA196082-03 Defining the role of mutant XPO1 in chronic lymphocytic leukemia HING, ZACHARY OHIO STATE UNIVERSITY OH $38,779
Lymphoma 2017 NCI 5U01CA183012-04 Stem Cell Gene Therapy Following R-EPOCH for Non-Hodgkin Lymphoma in AIDS Patient ZAIA, JOHN BECKMAN RESEARCH INSTITUTE/CITY OF HOPE CA $312,304
Lymphoma 2017 NCI 5R21CA206309-02 (PQ2) HIV INFECTION, APOBEC UPREGULATION, AND CANCER MUTAGENESIS HARRIS, REUBEN UNIVERSITY OF MINNESOTA MN $182,192
Lymphoma 2017 NCI 5R01CA206019-02 Host factors, tumor microenvironment and survival in a multiethnic study of Hodgkin lymphoma patients COZEN, WENDY UNIVERSITY OF SOUTHERN CALIFORNIA CA $816,487
Lymphoma 2017 NHLBI 5R01HL116217-05 Engraftment and in vivo selection of HIV-protected stem cells KIEM, HANS-PETER FRED HUTCHINSON CANCER RESEARCH CENTER WA $523,418
Lymphoma 2017 NIAID 5U19AI107810-05 8686 Study of Novel HHV8/KSHV Encoded Genes DAMANIA, BLOSSOM UNIVERSITY OF NORTH CAROLINA SYSTEM NC $405,042
Lymphoma 2017 NCI 5P30CA023100-31 6336 Hematologic Malignancies LIPPMAN, SCOTT UNIVERSITY OF CALIFORNIA SAN DIEGO CA $20,988
Lymphoma 2017 NCI 5R01CA189806-04 Impact of malaria on shaping immunity to EBV in the etiology of Burkitt lymphoma MOORMANN, ANN UNIV OF MASSACHUSETTS MED SCH WORCESTER MA $541,564
Lymphoma 2017 NIDDK 5K08DK100739-04 The Intraepithelial T cell Response in Celiac Disease HAN, ARNOLD COLUMBIA UNIVERSITY HEALTH SCIENCES NY $166,212
Lymphoma 2017 NIAID 5R01AI113130-02 New Therapeutics for Post-Transplant Lymphoproliferative Disorder MARTINEZ, OLIVIA STANFORD UNIVERSITY CA $398,138
Lymphoma 2017 NCI 5P01CA023766-38 6334 Clinical Trials Evaluating Transplant Strategies and Adoptive Cell Therapies to O'REILLY, RICHARD SLOAN-KETTERING INST CAN RESEARCH NY $400,570
Lymphoma 2017 NCI 5R01CA134451-08 Computer-based assessment of tumor microenvironment (TME) in Follicular Lymphoma GURCAN, METIN OHIO STATE UNIVERSITY OH $234,254
Lymphoma 2017 NCI 5R21CA210904-02 Core Essential Genes in Primary Effusion Lymphoma Cell Lines GOTTWEIN, EVA NORTHWESTERN UNIVERSITY AT CHICAGO IL $168,019
Lymphoma 2017 NCI 5R01CA182905-04 Protein-coding and non-coding RNA biomarkers for early detection of CLL CALIN, GEORGE UNIVERSITY OF TX MD ANDERSON CAN CTR TX $534,545
Lymphoma 2017 NCI 2P30CA006973-54 8084 Hematologic Malignancies and BMT Program - 02 AMBINDER, RICHARD JOHNS HOPKINS UNIVERSITY MD $55,302
Lymphoma 2017 NIGMS 1SC1GM122648-01 Ligand Guided Selection of Aptamers against Human Leukemia and Lymphoma MALLIKARATCHY, PRABODHIKA HERBERT H. LEHMAN COLLEGE NY $362,800
Lymphoma 2017 NCI 5R01CA096500-15 Role of KSHV viral proteins in signaling and pathogenesis DAMANIA, BLOSSOM UNIV OF NORTH CAROLINA CHAPEL HILL NC $281,108
Lymphoma 2017 NCI 1P01CA214278-01 8888 Project 1: Overcoming resistance of B cell leukemia to CD19 CAR T Cells. PORTER, DAVID UNIVERSITY OF PENNSYLVANIA PA $435,992
Lymphoma 2017 NCI 5R42CA183197-03 Developing Therapeutics That Target RAD51 To Treat Leukemia and Lymphoma MILLS, KEVIN CYTEIR THERAPEUTICS, INC. MA $961,015
Lymphoma 2017 NIGMS 5R35GM118009-02 Site-Specific Recombination in Human Health & Disease LIEBER, MICHAEL UNIVERSITY OF SOUTHERN CALIFORNIA CA $487,031
Lymphoma 2017 NCI 2P01CA087497-16A1 5245 Core C - The Molecular Systems Pathology Core CORDON-CARDO, CARLOS ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI NY $262,699
Lymphoma 2017 NCI 5R01CA194547-03 The identification and validation of mechanisms and biomarkers for relapse in diffuse large B-cell lymphoma ELEMENTO, OLIVIER WEILL MEDICAL COLL OF CORNELL UNIV NY $530,098
Lymphoma 2017 NCI 5R01CA095318-13 Role of B cells in murine gammaherpesvirus 68 SPECK, SAMUEL EMORY UNIVERSITY GA $368,305
Lymphoma 2017 NCI 5P30CA013696-43 6105 Lymphoid Development and Malignancy Program EMERSON, STEPHEN COLUMBIA UNIVERSITY HEALTH SCIENCES NY $35,133
Lymphoma 2017 NCI 5P30CA013696-43 6127 Recruitment EMERSON, STEPHEN COLUMBIA UNIVERSITY HEALTH SCIENCES NY $95,447
Lymphoma 2017 NCI 5U01CA194389-03 Modeling the Molecular Determinants of Induced Anti-Tumor Immune Responses in Mantle Cell Lymphoma ALIZADEH, ARASH STANFORD UNIVERSITY CA $643,804
Lymphoma 2017 NCI 5R01CA177734-05 Genetic Biomarkers for Risk Assessment of Peripheral T-Cell Lymphomas FELDMAN, ANDREW MAYO CLINIC ROCHESTER MN $329,925
Lymphoma 2017 NCI 5P30AI027757-30 7315 HIV-Associated Malignancies (HIVAM) CASPER, COREY UNIVERSITY OF WASHINGTON WA $36,372
Lymphoma 2017 NHLBI 5P30AI027757-30 7315 HIV-Associated Malignancies (HIVAM) CASPER, COREY UNIVERSITY OF WASHINGTON WA $26,039
Lymphoma 2017 NIA 5P30AI027757-30 7315 HIV-Associated Malignancies (HIVAM) CASPER, COREY UNIVERSITY OF WASHINGTON WA $1,874
Lymphoma 2017 NIAID 5P30AI027757-30 7315 HIV-Associated Malignancies (HIVAM) CASPER, COREY UNIVERSITY OF WASHINGTON WA $177,638
Lymphoma 2017 NICHD 5P30AI027757-30 7315 HIV-Associated Malignancies (HIVAM) CASPER, COREY UNIVERSITY OF WASHINGTON WA $7,688
Lymphoma 2017 NIDA 5P30AI027757-30 7315 HIV-Associated Malignancies (HIVAM) CASPER, COREY UNIVERSITY OF WASHINGTON WA $18,461
Lymphoma 2017 NIDDK 5P30AI027757-30 7315 HIV-Associated Malignancies (HIVAM) CASPER, COREY UNIVERSITY OF WASHINGTON WA $4,864
Lymphoma 2017 NIGMS 5P30AI027757-30 7315 HIV-Associated Malignancies (HIVAM) CASPER, COREY UNIVERSITY OF WASHINGTON WA $4,864
Lymphoma 2017 NIMH 5P30AI027757-30 7315 HIV-Associated Malignancies (HIVAM) CASPER, COREY UNIVERSITY OF WASHINGTON WA $18,194
Lymphoma 2017 NCI 5K08CA172215-05 The role of GATA-3 in T-cell lymphomas WILCOX, RYAN UNIVERSITY OF MICHIGAN MI $178,618
Lymphoma 2017 NCI 5R01CA206476-02 (PQ3) Identifying Novel Pharmacologic Risk factors for Common Non-AIDS Defining Cancers in Individuals with Well-controlled HIV Infection CHIAO, ELIZABETH BAYLOR COLLEGE OF MEDICINE TX $772,521
Lymphoma 2017 NCI 5K24CA184039-04 Molecularly Targeted Therapy for Lymphoma GOPAL, AJAY UNIVERSITY OF WASHINGTON WA $172,224
Lymphoma 2017 NCI 5K23CA184279-04 Molecular determinants of prognosis in limited-stage follicular lymphoma LOUISSAINT, ABNER MASSACHUSETTS GENERAL HOSPITAL MA $140,263
Lymphoma 2017 NIAID 5R21AI122035-02 Role of Nuclear Lamina in the epigenetic regulation of Epstein-Barr Virus Infection TEMPERA, ITALO TEMPLE UNIV OF THE COMMONWEALTH PA $195,000
Lymphoma 2017 NCI 5R01CA197801-03 Identification of Loci Modifying Atm Lymphomagenesis WEIL, MICHAEL COLORADO STATE UNIVERSITY CO $343,463
Lymphoma 2017 NCI 5K08CA191019-04 The Role of ZEB1 Mutations in Cutaneous T Cell Lymphoma CHOI, JAEHYUK NORTHWESTERN UNIVERSITY AT CHICAGO IL $152,388
Lymphoma 2017 NCI 1K99CA215307-01 Glycine metabolism in cancer DUCKER, GREGORY PRINCETON UNIVERSITY NJ $99,004
Lymphoma 2017 NCI 5R01CA170006-06 Microvesicle Dynamics in B-Cell Chronic Lymphocytic Leukemia Tumor Microenvironme GHOSH, ASISH UNIVERSITY OF OKLAHOMA HLTH SCIENCES CTR OK $305,069
Lymphoma 2017 NCI 5F30CA189740-04 Alternative End-Joining in DNA Repair and Chromosomal Translocations KUMAR, VIPUL HARVARD MEDICAL SCHOOL MA $49,044
Lymphoma 2017 NCI 5R01CA130995-10 Replication Licensing in Genome Stability, Cancer and Aging PRUITT, STEVEN ROSWELL PARK CANCER INSTITUTE CORP NY $324,743
Lymphoma 2017 NCI 5R01CA163910-06 TARGETING ANTIGEN-INDUCED ER STRESS RESPONSE IN B-CELL CHRONIC LYMPHOCYTIC LEUKEM HU, CHIH-CHI WISTAR INSTITUTE PA $380,146
Lymphoma 2017 NCI 5R01CA197945-03 The role of RHOA G17V mutation in peripheral t-cell lymphomas PALOMERO, TERESA COLUMBIA UNIVERSITY HEALTH SCIENCES NY $366,000
Lymphoma 2017 NCI 5R01CA140337-07 Host pathways regulating Epstein-Barr virus-mediated B cell growth transformation LUFTIG, MICAH DUKE UNIVERSITY NC $371,732
Lymphoma 2017 NCI 5R01CA206404-02 Investigating the development of AIDs and non-AIDS defining cancers in aged SIV-infected rhesus macaques. WONG, SCOTT OREGON HEALTH & SCIENCE UNIVERSITY OR $1,555,244
Lymphoma 2017 NCI 5R01CA086065-18 HSC Diversity, in aging, ontogeny, and transformation WEISSMAN, IRVING STANFORD UNIVERSITY CA $410,288
Lymphoma 2017 NIAMS 5R01AR063962-05 CTCL immunobiology: lessons from alemtuzumab CLARK, RACHAEL BRIGHAM AND WOMEN'S HOSPITAL MA $366,977
Lymphoma 2017 NCI 5U01CA166905-05 Identifying non-coding RNAs for early detection and prevention of lung cancer CROCE, CARLO OHIO STATE UNIVERSITY OH $915,659
Lymphoma 2017 NCI 5U01CA195568-03 The Lymphoma Epidemiology of Outcomes (LEO) Cohort Study CERHAN, JAMES MAYO CLINIC ROCHESTER MN $2,248,270
Lymphoma 2017 NIDCR 5R01DE024971-03 Platform technology for detection of cancer-associated viruses in HIV patients DEMIRCI, UTKAN STANFORD UNIVERSITY CA $423,242
Lymphoma 2017 NCI 1R21CA205106-01A1 A novel VLP vaccine to prevent EBV infection and EBV - associated malignancies OGEMBO, JAVIER BECKMAN RESEARCH INSTITUTE/CITY OF HOPE CA $234,992
Lymphoma 2017 NCI 5F30CA203292-02 Chromatin dysregulation generated by recurrent point mutation in histone methyltransferase, MMSET, drives progression of lymphoid malignancies SWAROOP, ALOK UNIVERSITY OF FLORIDA FL $38,371
Lymphoma 2017 NCI 5P01CA016038-43 7371 Project 1, Miller: Novel Functions of the Epstein-Barr Viral Lytic Cycle Activator Protein ZEBRA MILLER, I. YALE UNIVERSITY CT $197,935
Lymphoma 2017 NCI 5P01CA016038-43 7373 Project 3, Steitz: Viral Noncoding RNAs and Cell Transformation STEITZ, JOAN YALE UNIVERSITY CT $123,787
Lymphoma 2017 NCI 5R01CA187799-03 Role of FOXP1 and WNT signaling in B-cell Lymphoma MAJOR, MICHAEL UNIV OF NORTH CAROLINA CHAPEL HILL NC $307,500
Lymphoma 2017 NCI 5R01CA196703-03 Mechanisms of resistance to ALK inhibitors in ALK-rearranged lymphoma CHIARLE, ROBERTO BOSTON CHILDREN'S HOSPITAL MA $404,888
Lymphoma 2017 NCI 5R01CA201309-02 How HTLV-I Tax and HBZ control telomerase activity to induce adult T-cell leukemia NICOT, CHRISTOPHE UNIVERSITY OF KANSAS MEDICAL CENTER KS $347,168
Lymphoma 2017 NCI 5R01CA187040-05 Targeting SIRT1 in Mantle Cell Lymphoma SETO, EDWARD GEORGE WASHINGTON UNIVERSITY DC $274,620
Lymphoma 2017 NCI 5R01CA202712-02 Risk factors for molecular subtypes of NHL a prospective evaluation WANG, SOPHIA BECKMAN RESEARCH INSTITUTE/CITY OF HOPE CA $830,007
Lymphoma 2017 NCI 5P01CA190193-03 8720 Project 1: Direct & Repeated pO2 Measurements for Cancer using EPR with Carbon Pa KUPPUSAMY, PERIANNAN DARTMOUTH COLLEGE NH $476,425
Lymphoma 2017 NCI 5R21CA209107-02 Molecular Pathways of Interleukin-13 in Cutaneous T-cell Lymphoma FUSCHIOTTI, PATRIZIA UNIVERSITY OF PITTSBURGH AT PITTSBURGH PA $167,831
Lymphoma 2017 NCI 5K24CA208132-02 Mentored Patient Oriented Research in Lymphoma FLOWERS, CHRISTOPHER EMORY UNIVERSITY GA $164,375
Lymphoma 2017 NCI 1R01CA216273-01 (PQ8) Genetically faithful murine models for studying disease progression in chronic lymphocytic leukemia WU, CATHERINE DANA-FARBER CANCER INST MA $701,924
Lymphoma 2017 NCI 5R21CA202104-02 Overcoming Primary Ibrutinib Resistance in Mantle Cell Lymphoma Using Patient-Derived Models and Molecular Profiling WANG, MICHAEL UNIVERSITY OF TX MD ANDERSON CAN CTR TX $174,000
Lymphoma 2017 NCI 5UH2CA202637-02 Smartphone for molecular cancer diagnostic in Africa WEISSLEDER, RALPH MASSACHUSETTS GENERAL HOSPITAL MA $491,375
Lymphoma 2017 NCI 1R01CA208352-01A1 Targeting Mdm2-MdmX E3 Ligase for Treatment of Drug-Resistant Lymphoma WANG, XINJIANG ROSWELL PARK CANCER INSTITUTE CORP NY $390,710
Lymphoma 2017 NCI 5R01CA197870-03 Improving BTK Directed Therapy for CLL WOYACH, JENNIFER OHIO STATE UNIVERSITY OH $352,275
Lymphoma 2017 RMAP 5K01ES025431-05 The role of epigenetic heterogeneity in CLL evolution LANDAU, DAN WEILL MEDICAL COLL OF CORNELL UNIV NY $187,920
Lymphoma 2017 NCI 5R01CA207513-02 Role of KLHL6 inactivation in mature B-cell malignancies BUSINO, LUCA UNIVERSITY OF PENNSYLVANIA PA $368,288
Lymphoma 2017 NCI 5R01CA203836-02 Monocyte promotion of therapy resistance by immune and non-immune mechanisms LIN, YI MAYO CLINIC ROCHESTER MN $363,713
Lymphoma 2017 NCI 5R44CA153474-03 Virus-targeted therapeutic for EBV-Associated Malignancies PERRINE, SUSAN PHOENICIA BIOSCIENCES, INC. MA $519,583
Lymphoma 2017 NCI 5R01CA206462-02 SIRT2 Inhibitors for the Treatment of B-cell Lymphoma SIMON, JULIAN FRED HUTCHINSON CANCER RESEARCH CENTER WA $574,754
Lymphoma 2017 NCI 5R01CA200703-02 Genetic Epidemiology of non-Hodgkin Lymphoma CERHAN, JAMES MAYO CLINIC ROCHESTER MN $662,837
Lymphoma 2017 NCI 5R01CA188794-04 Cell cycle reprogramming for therapeutic targeting of BTK in lymphoma CHEN-KIANG, SELINA WEILL MEDICAL COLL OF CORNELL UNIV NY $351,713
Lymphoma 2017 NCI 5P30CA091842-16 6313 Hematopoietic Development and Malignancy (Project-002) EBERLEIN, TIMOTHY WASHINGTON UNIVERSITY MO $64,408
Lymphoma 2017 NCI 5R01CA161151-05 Lig4R278H contribution to HSC and IgH class switching defects and malignancies YAN, CATHERINE BETH ISRAEL DEACONESS MEDICAL CENTER MA $381,305
Lymphoma 2017 NCI 5R21CA202358-02 Targeting Beta-Adrenergic Signaling to Control GVH and GVL Responses CAO, XUEFANG ROSWELL PARK CANCER INSTITUTE CORP NY $189,334
Lymphoma 2017 NCI 5F30CA210539-02 Epigenetic activity of normal and cancer-associated mutant H1 linker histones HEALTON, SEAN ALBERT EINSTEIN COLLEGE OF MEDICINE, INC NY $44,044
Lymphoma 2017 NCI 5P30CA016086-41 8627 EARLY PHASE CLINICAL RESEARCH SUPPORT (Core 020) DEES, ELIZABETH UNIV OF NORTH CAROLINA CHAPEL HILL NC $281,916
Lymphoma 2017 NCI 5R21CA209341-02 Repurposing statins to enhance efficacy of BCL-2 antagonists in blood cancer FRUMAN, DAVID UNIVERSITY OF CALIFORNIA-IRVINE CA $197,737
Lymphoma 2017 NIGMS 5R01GM106067-04 DNA-carbon Assemblies for Multispectral Imaging KOOL, ERIC STANFORD UNIVERSITY CA $303,533
Lymphoma 2017 NLM 1R21LM012395-01A1 Deconvolution of Epigenomic Data to Characterize Cellular Subpopulations EDWARDS, JOHN WASHINGTON UNIVERSITY MO $220,064
Lymphoma 2017 NIGMS 5R01GM095606-07 Drug-Free Macromolecular Therapeutics KOPECEK, JINDRICH UNIVERSITY OF UTAH UT $298,000
Lymphoma 2017 NCI 5R01CA114536-12 TARGETING ROR1 WITH CHIMERIC ANTIGEN RECEPTOR MODIFIED T CELLS RIDDELL, STANLEY FRED HUTCHINSON CANCER RESEARCH CENTER WA $458,731
Lymphoma 2017 NCI 5R01CA190628-03 Overcoming Resistance to Anti-EGFR Therapy by Drug Repurposing FANG, BINGLIANG UNIVERSITY OF TX MD ANDERSON CAN CTR TX $514,090
Lymphoma 2017 NCI 5F31CA210429-02 WDR5 as a Critical Co-Factor for MYC FOSHAGE, AUDRA VANDERBILT UNIVERSITY TN $28,716
Lymphoma 2017 NIDDK 5R01DK067180-13 Innate and adaptive immunity in celiac disease JABRI, BANA UNIVERSITY OF CHICAGO IL $531,480
Lymphoma 2017 NCI 5R01CA139083-09 Recognition and Targeting of CNS Lymphoma by Tumor-Associated Macrophages RUBENSTEIN, JAMES UNIVERSITY OF CALIFORNIA, SAN FRANCISCO CA $370,554
Lymphoma 2017 NCI 5R01CA187109-04 Targeting EZH2 in Germinal Center Derived B-Cell Lymphoma MELNICK, ARI WEILL MEDICAL COLL OF CORNELL UNIV NY $492,647
12


  • Download Readers:
  • Download Adobe PDF Reader
  • Download Microsoft PowerPoint Viewer
  • Download Microsoft Word Viewer
  • Download Microsoft Excel Viewer